ARTICLE | Emerging Company Profile
cellvie: Reviving cell metabolism via mitochondrial transplant
Harvard spinout using mitochondrial transfer to treat ischemia-reperfusion injury after kidney transplant
September 25, 2021 2:28 AM UTC
Harvard spinout cellvie is pioneering therapeutic mitochondria transplantation as a way to rescue cell energy metabolism and save cells that would otherwise die.
James McCully, a cellvie Inc. co-founder, developed the approach at Harvard Medical School to ameliorate ischemia-reperfusion injury, which is the tissue damage caused when blood supply returns after a period of ischemia...